 I think nowadays, you know, to do effective science, it's important to pursue multidisciplinary approaches. And certainly industry and academia have different angles on things and different areas of expertise. I mean, Frank is a pharmacologist and obviously, Ionis, that's their strength and they're very focused on antisense technology. And so we do more basic biochemistry and molecular biology. We have been studying RNA splicing mechanisms for over three decades. And so when you bring it all together, I think it's very powerful and we were able to learn a lot from each other and to get things done that I think would have been perhaps impossible for either team to do alone.